The Genetic Epidemiology and Risk Assessment Program of the Mayo Clinic Cancer Center combines large observational studies with cutting-edge molecular technologies and statistical analyses to explore important questions about human cancer. Program investigators seek to understand why cancer develops, how to best prevent cancer, and how to improve diagnosis, treatment and outcomes for cancer patients.
To support these efforts, investigators in the Genetic Epidemiology and Risk Assessment Program enroll large numbers of people in studies that include patients with cancer and their family members, as well as people with no history of cancer to serve as controls.
The specific goals of the Genetic Epidemiology and Risk Assessment Program are to:
- Understand genetic, environmental and gene-environment interactions in the causes of cancer
- Understand the genetic and molecular epidemiology of cancer outcomes and survivorship
- Develop and apply novel statistical and informatics methods for the design and analysis of genetic and molecular epidemiology studies